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Abstract
Recently, in a joint cooperation of Stichting VNA, SAL Apotheken, the Faculty of
Management and Organization, and the University Centre for Pharmacy, University
of Groningen in the Netherlands, a Ph.D-study started regarding Apot(he)ek,
Organization and Management (APOM). The APOM-project deals with the structur-
ing and steering of pharmacy organization. The manageability of the internal
pharmacy organization, and the manageability of the direct environment of pharmacy
organization is the subject matter. The theoretical background of the APOM-project
is described. A literature study was made to find mixes of objectives. Three mixes
of objectives in pharmacy organization are postulated; the product mix, the process
mix, and the customer mix. The typology will be used as a basic starting point for
the empirical study in the next phase of the APOM-project.
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Introduction
Organization studies have become increasingly important for the management of
pharmacy organization. The studies cover a diversity of issues, for example, financial
management, personnel management, organization structure, types of pharmacy
managers et cetera. The pharmacist is becoming ’pharmacy manager’. The pharmacy
manager is working on pharmaceutical tasks as well as managerial tasks. Structuring
and steering of organizational processes are important to have a clear vision of the
pharmacy as an organization. In November 1994, in a joint cooperation of Stichting
Verenigde Nederlandse Apotheken (VNA), Stichting Apothekers in Loondienst
(SAL) Apotheken, the Faculty of Management and Organization and the University
Centre for Pharmacy (University of Groningen) in the Netherlands, a Ph.D-study
started regarding Apot(he)ek, Organization and Management (APOM). The APOM-
project deals with the structuring and steering of pharmacy organization and will
take four years. The study should lead to improved manageability of pharmacy
organization.
In the APOM-project, firstly, it is assumed that pharmacy managers aim for good
quality in the provision and use of medicine, and, in addition, that the way in which
pharmacy managers interpret good quality varies. However, it is assumed that there
is no ’one best way’ to organize quality, since different opinions exist about the
interpretation of good quality. A pharmacy manager will steer pharmacy organization
by stressing a certain package of organizational tools, for example, good quality of
the medicine in order to meet specific standards, minimilizing risk, and minimilizing
error occurrence. In addition, pharmacy manager can stress, for example, customer
satisfaction or profitability and efficiency. Firstly, the study analyzes whether
pharmacy managers steer internally consistent. It is analyzed whether pharmacy
managers act as they say they do. By analogy with the contingency approach,
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consistent steering or organizational ’fit’ is expected to lead to effective structuring.
It is assumed that correspondence of thinking and acting will lead to improved
manageability. For example, it is analyzed whether a pharmacy manager who
assumes that he/she is in the customer mix actually does stress customer-related
activities, and not only product and check.
In the APOM-project, secondly, it is assumed that over the last years the customer
is becoming increasingly important within pharmacy organization. Within this
developing context, a customer-based pharmacy organization, the actual change of
pharmacy organization to the customer mix and the managerial problems in the
organizational change will be described. The expected result of the APOM-project
is improved manageability of pharmacy organization.
Within this paper the theoretical background of the APOM-project is described.
Pharmacy manager selects objectives related to the economic sustainability of the
pharmacy organization. The selection of the set of objectives will lead to a certain
steering mix; the sum total of steering measures which structures the organization.
A literature study was made to find mixes of steering measures, or objectives. Based
on the material a typology is presented. The study describes three pharmacy mixes,
the product mix, with an emphasis on product and check; the process mix, with an
emphasis on money, and the customer mix, with an emphasis on customer satisfacti-
on. The typology is used as a basic starting point for the empirical study in the next
phase of the APOM-project.
Background of the Study
Pharmacies, as well as other organizations, mostly have consensus of their primary
role in society, the purpose. For example, the purpose of a pharmacy can be
described as the supply of medicine to the population. In most of the legislation
passed within the last two decades this basic task comprises at least the control,
storage and supply of medicines, as well as their preparation and their development
and manufacture on a larger scale. In addition, to the basic task there has increas-
ingly been a recognition or imposition of other tasks, in particular the provision of
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information and counselling with regard to medicines, counselling in preventive
health care, the notification of suspected adverse reactions, medication surveillance,
and, on the research front, a role in the quest for new medical substances and forms
of administration [1]. The mission of pharmacies is the unique reason for its existen-
ce; that which sets pharmacies apart from all other organizations. Although the terms
"purpose" and "mission" are often used interchangeably, to distinguish between them
may help in the understanding of organizational goals [2]. In many countries, good
quality of the provision and use of medicine, would be such a mission. Within the
broad limits of its purpose, each organization chooses a mission that can be
described in terms of products and markets, services and customers [2]. Over the
last fifty years the pharmacy, for example, has redefined its mission, shifting the
emphasis of its operations away from the production of medicine to the support of
pharmacotherapy and the provision of information [3], in order to improve drug use.
The purpose of an organization is its primary role in society; the mission of an
organization is the unique reason for its existence. In addition, in Organization
Theory, it is well known that missions can be translated into various objectives that
an organization must reach in order to achieve its goals [2]. For example, individual
pharmacists can assert their own interpretation on the mission by stressing one or
more objectives. The objectives may be described by the productivity of the
pharmacy, the quality of the services given to the customer, or a variety of other
ways.
Despite consensus of purpose, pharmacy managers interpret good quality in different
ways. Several studies showed different opinions about the interpretation of good
quality [4, 5, 6, 7, 8, 9], for example, an emphasis on good quality of medicines,
good quality of revenue or good quality of information. In addition, differences in
the interpretation of good quality can vary over time. Organization objectives should
not be regarded as an unchangeable set of goals. The objectives should be viewed
as open to amendment and will change as strategies develop [10]. Pharmacists
approached quality from their own point of view in the past; the back door of the
pharmacy. With a little exaggeration: good quality was perceived in relation to the
purchase of medicine and the production of preparations. Currently, pharmacists
3
approach quality from the point of view of the patient; the front door of the
pharmacy. Good quality is related to the perception of the patient [11]. Quality, in
this view, can only be good if pharmacy organization is tuned precisely to the wishes
of the patient.
Pharmacy managers are able to compose a certain set of objectives. A pharmacy is
obviously a small organization. Many small organizations have an entrepreneurial
mode of strategy making [12]. This means that the strategy-making process tends
to be highly intuitive and non analytical. It is not, therefore, surprising that the
resulting strategy, seldom made explicit, reflects the chief executive’s implicit vision
of the position of the organization in its environment. In fact, that strategy is more
often than not a direct extrapolation of his personal beliefs, an extension of his own
personality [13]. The pharmacy manager can design pharmacy organization by selec-
ting a specific set of internally consistent objectives. This selection will lead to a
certain steering mix; the sum total of steering measures which structure the organi-
zation [14]
Pharmacy managers deal with the manageability of the internal pharmacy
organization, and the manageability of the direct environment of pharmacy
organization. Pharmaceutical care is not provided in isolation from other health-care
services, but in collaboration with patients, physicians and other health-care
providers [15, 16, 17]. The pharmacist will have to characterize the pharmacy as a
link in the total health-care system. For example, the pharmacist could concentrate
on the consultation with general practitioners, with specialists, and with patient
associations. In addition, the pharmacist could concentrate on the cooperation within
the pharmaceutical business chain, and on the relations with home nursing services
[16]. In addition, some aspects of pharmaceutical care can be defined. Firstly, the
pharmaceutical care for the community; pharmacists individually and as a profession
have important roles to play in positively influencing drug policy, drug use and
outcomes as well as other aspects of health care. In many instances, firstly,
pharmaceutical care should take place through collaboration with other health
professionals at community level. Secondly, pharmaceutical care should be for
4
individual patients, the so-called comprehensive pharmaceutical care, the delivery
of which requires an ongoing, covenantal relationship between pharmacist and
patient [15]. In addition, pharmaceutical care can be defined as the intensive care
by the pharmacist in order to achieve an optimal pharmacotherapy in which the
patient and the patient’s complaint(s) are at the centre in order to realize an optimal
quality of life [18, 19, 20].
The pharmacy manager can design pharmacy organization in a variety of ways.
Pharmacy organization can be designed by, for example, care and money. Firstly,
pharmacy organization provides care as a part within the pharmaceutical business
chain. The pharmacy manager selects objectives related to the care for the patient.
Secondly, pharmacy organization, as well as any other organization, needs turnover
in order to sustain its activity. Pharmacy manager selects objectives related to the
economic sustainability of the pharmacy organization. The selection of the set of
objectives will lead to a certain steering mix; the sum total of steering measures
which structure the organization. In the APOM-project three pharmacy mixes are
defined related to the care orientation and to the economic orientation.
Three pharmacy mixes
Three pharmacy mixes of objectives are
Figure 1 Three mixes of objectives in
pharmacy organization; product mix,
process mix and customer mix.
described (figure 1); the product mix, the process
mix, and the customer mix. Although several
studies have resulted in the description of differ-
ent types of pharmacy or different types of
pharmacist [21, 22, 23, 24, 25] it is assumed here
that there is no ’one best way’ to organize
quality. The pharmacy manager should seek to
find internally consistent positions within one of
the three pharmacy mixes, in order to be able to
steer and structure pharmacy organization. Why
is consistency such an important issue here?
Mainly, the importance of consistency is related to effectiveness. It is assumed that
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improved leads to more effective organizations. In addition, with respect to internal
consistency, one of the prime purposes of strategic analysis is to provide a clear
picture of the organization and the environment in which it is operating. A useful
summary of this situation might include a listing of the major opportunities and
threats which face the organization, its particular strengths and weaknesses and any
objectives which are a particulary important influence on policy [10]. In the APOM-
project, internal consistency relates to the fit of the organization strategy with its
objectives selected by the pharmacy manager. For example, if pharmacy manager
intends to attain maximum customer satisfaction, would the set of selected objectives
be likely to achieve maximum customer satisfaction? At this stage, the pharmacy
mixes are described in a pure form; it is assumed for the moment that they are
internally consistent.
The product mix
The product mix deals with, the specific standards the medicine should meet, the
minimilization of risks, and the minimilization of error occurrence. The pharmacy
manager designs pharmacy organization with an emphasis on product and check.
With respect to the product, it should be common to have a formulary of some kind
compiled within the pharmacy system of a country, in order to standardize
extemporaneous preparations; e.g. in close cooperation with experts working at
faculties of pharmacy [1]. With respect to the check, it seems sensible to know
where the responsibility lies for ensuring the correctness of a prescription. In Dutch
law, for example, a pharmacist was legally allowed in refusing to dispatch a
medicine without prescription, if, in the view of the pharmacist, the patient ought
to consult a general practitioner first [26]. The pharmacist can be held responsible
if it is showed that the medicine is dispatched too lightly. In addition in English law,
for example, a related issue was decided by a court of law in the so-called "Migril
case" [1983] where, although a prescription had been correctly dispensed according
to the doctor’s instructions, it was held judicially that the pharmacist should have
questioned the dosage specified which was, in fact, a cumulative overdose. The
patient developed gangrene in both feet and substantial damages were awarded
against both the doctor and the pharmacist. Such examples form the clearest
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recognition by society that the pharmacist’s legal responsibility extends beyond the
accuracy with which a prescription is dispensed and involves the nature of the
prescription itself and the manner in which it is made available to the patient [1].
In addition, a pharmacy can be defined as a constellation of working stations with
defined tasks. Within the product mix a certain working station and related tasks
will be expected to be stressed. The pharmacy organization has roughly five working
stations. At working-station 1 (receival) counter, the prescription is received. At
working-station 2 computer, the data concerning the patient and the prescription are
put into the computer. At working-station 3 filling, the prescribed medicine is col-
lected/produced. At working-station 4 check, the filled/produced prescription is
checked. At working-station 5 (delivery) counter, the medicine is handed over to
the customer. Several measures can be taken to assure the safety of the dispensed
medicine at various working stations and by using various organizational systems
in pharmacy organization. The dispensing of the medicine can be organized in
various ways by dividing the (set of) task(s) of the working stations over several
persons; resulting in various working systems [27]. For example, the pharmacist can
decide to stress the activities of one or more working stations; in the product mix
for example, the working station check would be likely to be stressed. In several
countries the check is organized in different ways. For example, the Dutch quality
system with respect to extemporaneous preparations comprises laboratories
(Laboratorium Nederlandse Apothekers), standardized therapeutic relevant regulations
(Formularium der Nederlandse Apothekers; FNA), production records (chargebere-
idingsvoorschriften), Regional Pharmacy Laboratories (RAL) coordinated by Central
Consultative Body Regional Pharmacy Laboratories (CORAL), and a post-academic
course of quality guarantee [28]. In addition, the standards for Dutch pharmacists
(AWEK) describe the organization of dispensing medicine. Each pharmacy is free
to take its own decision about the use and interpretation of the AWEK standards;
AWEK is not legally obliged. In addition, the pharmacy manager can design the
working organization in various ways, and still work according to AWEK. The
filling of the prescription should be done by various persons to guarantee a good
check, according to AWEK standards. One pharmacy assistant receives the
prescription and dispenses the medicine. A second pharmacy assistant works at the
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computer. A third pharmacy assistant collects the prescribed medicine. The third
pharmacy assistant checks the printed label and sticks the label on the medicine
packs; this assistant is responsible for the correctness of the medicine and the label
[29]. In the short term, the AWEK standards will be substantially revised, and will
be renamed Nederlandse Apotheeknorm (NAN standards). In the Netherlands, the
dispensing of the medicine of pharmacists is checked in the same way as the
dispensing of the pharmacy assistants; all personnel is allowed to check each other.
In addition, in Sweden the check is organized differently than in the Netherlands.
At Swedish pharmacies, for example, three types of staff dispense medicine.
Pharmacists (4 years university study), prescriptionists (2 years university study) and
technicians (intermediate vocational education) have different responsibilities. Firstly,
pharmacists can dispense medicine on their own. Secondly, presciptionists can
dispense medicine on their own. Thirdly, technicians can dispense medicine, but
have to be checked by a pharmacist/prescriptionist; this system results in two
varieties of making checks. The first variety is that the pharmacy staff perform it
the way the law prescribes. This means that a pharmacist/prescriptionist fills a
prescription on his/her own. A technician is checked by a pharmacist/prescriptionist
(standard industry packs of medicine). If the prescribed medicine is, for instance,
an extemporaneous medicine, the technician leaves the working station filling to the
pharmacist/prescriptionist. The second variety is when the pharmacy takes the
decision to have a "double check". This means that everybody needs a check:
prescriptionists/pharmacists as well as technicians. This also means that two persons
are responsible for the filling of each prescription. In this situation, the technician
is allowed to make the "double check". Each pharmacy is free to take its own
decision about the "double check" [30].
Pharmacy organization is structured in order to attain highest product quality and
product safety. In Dutch community pharmacies the computer is used today in an
ambitious system of prescription handling, in which product quality and product
safety are closely guarded. The four most important files relate to the patient, the
preparation, the medication history, and the financial record. The system renders
possible valuable checks of possible interactions, special dosage requirements, contra
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indications and even compliance [31] et cetera. In addition, the system can be used
to produce tables and other means in order to support the steering of pharmacy
organization.
The main objective of pharmacy organization in the product mix is to maximize
safety and quality with the least risk. Although risks can become infinitesimally
close to zero, the concept of "absolute safety" (zero risk) implies perfect foresight
and is therefore an ideal which is not attainable. Risk management is the making
of decisions concerning risks and their subsequent implementation, and flows from
risk estimation and risk evaluation [32]. The determination of "safety" does not
involve a measurement, but a judgement based on the acceptability of risk, usually
taking into consideration not only the measured risk, or risks, but also the benefits
and alternative risks at the very least [33].
The process mix
The process mix deals with the way in which the dispensing of the prescription is
organized, and to what extent it is organized profitably and efficiently. The
pharmacy manager designs pharmacy organization with an emphasis on money. With
respect to this issue, pharmacies pay attention to financial management. Financial
management focuses on making wise decisions about obtaining and using financial
resources. Pharmacy managers face many financial decisions, for example, how
much inventory to carry, whether to participate in third-party prescription plans,
whether to buy a new computer, and so on. The principal goal of financial
management is to increase the value of the organization. This goal is achieved by
making the most efficient use of financial resources. Pharmacies, for example, carry
inventories of prescription and non-prescription drugs. They must invest money in
order to buy inventories. Pharmacies make most efficient use of inventories when
they carry the smallest amount of stock necessary to meet consumer demand.
Carrying larger stock is a waste of resources because it takes money away from
other, more productive uses [34].
9
Pharmacy organization is structured in order to attain highest productivity.
Productivity is the relation of a quantity measure of outcome (measured in pieces,
kilograms et cetera) to a quantity measure of effort of production factors (measured
in working hours, units of means of production, units of means of raw materials)
[35].
The main objective of pharmacy organization in the process mix is to maximize
productivity at lowest cost. With respect to working organization of pharmacies,
maximizing productivity could be attained by, for instance, a re-design of a more
efficient organization which can then achieve more prescriptions per pharmacy
assistant in the same time. With respect to working organization of pharmacies, cost
reduction could be attained by, for instance, a re-design of a more efficient
organization in order to do the same amount of work with less (qualified) personnel,
or to achieve more work with the same quantity of (qualified) personnel, both in
the same time. In relation to productivity and cost, two types of economic evaluation
can be defined.
The first method is effectiveness evaluation; a method in which the consequences
of the alternatives are examined. The second method is cost analysis; a method in
which only costs are examined [36]. To accomplish a full economic evaluation both
the costs (inputs) and consequences (outcomes) of the competing alternatives must
be examined [37]. Refined methods are used by groups of pharmacies, for instance
by Boots in the United Kingdom or the Royal Dutch Association for the
Advancement of Pharmacy in the Netherlands, and, in addition, ideas of these
methods are roughly used by individual pharmacy managers. A method or
combination of methods can be used to attain maximize outcome or minimize cost.
The customer mix
The customer mix deals with the way in which the wishes of the customers are met.
The pharmacy manager designs pharmacy organization with an emphasis on custo-
mer. Systematic time and motion studies in Czechoslovakian pharmacies have led
to quite clear concepts as to what a pharmacy should provide in terms of facilities
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if it is to meet the patient’s needs. These studies culminate in the concrete definition
of a specific dispensing unit known as "dispensing module". The module is mostly
of a circular shape in which the worker is assumed to be the cylinder axis and on
this assumption he can reach the same distance in all directions. This module was
in fact put into operation as early as 1963. Similar installations have also appeared
in the USA and later the (former) Soviet Union in 1971 [38]. In Sweden, the idea
of a circular shape was used in the development of the carrousel by Apoteksbolaget
AB and Sintek; a round compact storage system for medicine with horizontally
revolving shelves. The carrousel can be used for different purposes at the same time;
two staff can serve customers directly from stock, while a third person replenishes
it. In the Netherlands the carrousel is used in the counter model which was designed
by Farmac under the authority of SAL Apotheken; inspired by Swedish examples.
The counter model integrates tasks in dispensing medicine: from working stations
on several locations with several persons, to working stations on one location with
fewer persons. One person fills the prescription at the counter which is then checked
by another person [27].
Pharmacy organization is structured in order to attain highest service quality. Service
quality should be more than just dispensing medicine. The pharmacist is responsible
for more than the delivery of a product to the ultimate consumer. It is certain that
he should be responsible for reinforcing the physician’s instructions about drug
therapies. He should be responsible for keeping patient-drug-utilization records. The
pharmacist should not only dispense drugs, but he should both dispense and elicit
information concerning drug usage and concerning the patient [39].
The main objective of pharmacy organization in the customer mix is to maximize
customer satisfaction. Several methods of measuring the level of patient satisfaction
are used in pharmacies in different countries. The most direct way is simply to ask
them for their views on the subject. Another less direct way involves inferring
attitudes from behaviour that is elicited essentially for other purposes, for example,
by studying the pronouncements and writings of individuals and groups [40]. In
Sweden, Apoteksbolaget AB was the first to monitor customer satisfaction on a
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national level with the National Customer Satisfaction Barometer (CSB) at
pharmacies; the direct way of measuring patient satisfaction. In 1992 in the Nether-
lands, this technique has been supported by KNMP and VNA and has been used
by Stichting Health Base ever since. Customer Satisfaction Projects have been made,
for example, in the province Zeeland and the city of Deventer by the end of 1993.
These studies comprise a survey for patients and a survey for the personnel [41, 42].
The customer satisfaction index can be described as the counterpart to productivity
measures. Whereas productivity refers to quantity of output, CSB measures quality
of output (as experienced by the customer) [43].
Changing to the customer mix
In most Western countries pharmacy managers seek to structure their organization
in accordance with the customer mix. Some years ago in the British health-care
system, changing market conditions exposed the dilemma between the pharmacist
as an entrepreneur and the pharmacist as a care worker. The Nuffield commission
stressed the urge of a professional pharmacist in his/her role as a care worker [44].
The Nuffield report showed an emphasis on processing the dispensation of
prescriptions at minimal cost in some health-centre pharmacies. As a result, the
service provided in these health-centre pharmacies was worse than elsewhere. The
report showed that independency and credibility were endangered if pharmacies gave
high priority to financial profit. On the contrary, the pharmacist as a care worker
can give independent advice, and is credible for general practitioners, as well as for
patients, despite all threats from the commercial environment. To guarantee the
professional occupation of pharmacists; two measures were recommended. Firstly,
the commission recommended the payment of consultation with practitioners, the
payment of the provision of information to the patient, the payment of medication
surveillance and so on. This measure was recommended, since advice brings no
financial return; the sale of medicine does. In this situation the pharmacist
concentrates on maximizing the sale of medicines. This was regarded as an important
barrier to change pharmacies in accordance with other active participants in the
health-care system, in order to attain high-quality service. Secondly, the commission
recommended that the profession of pharmacists should be led rather by professional
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responsibility than by laws, regulations, and so on. In Great Britain, many
pharmacies are owned by non-pharmacists; these pharmacists especially should have
an independent professional responsibility [45]. The pharmaceutical information task
was regarded as the most important part of the work. In Germany, medicine advice
is mostly regarded as a bonus free of charge: advice is normally given as an
additive. The pharmacy manager as a medicine expert tends to solve all problems
of patients with medicine; whether he wants to or not. Concerning this part he has
good reason to feel competent. In this view the pharmacy would be a place for the
sale of medicine and equally a place for the sale of advice [46]. In today’s market,
it is not sufficient to ensure high levels of productivity, the quality of what is
produced is becoming increasingly important [43]. Distributing drugs in a
productively way, no longer suffices today to convince broad segments of society
of the legitimacy and value of private corporate dealings. A growing part of our
society wants to know not only how much a corporation earns, but also how these
earnings are achieved [47]. Current changes in health policy towards the community
and self-care make it necessary that the pharmacist functions fully in the community
and not only within the walls of his pharmacy [1]. In the Netherlands in a study,
it was found that pharmacists think that the additional value of the pharmacy is
service (good and quick) and supply of information [26]. In this context, patient-
friendly activities consist of information and the delivery of medicine at home. In
an earlier study [3], it was showed that important target groups of pharmacy
organization did not know what the additional value of the pharmacy was. It was
concluded that the pharmacy should be actively marketing these values. Not in the
sense of "maximizing the sale of medicine", but marketing in the sense of
anticipating the needs and wishes of the environment; environment-oriented thinking.
Conclusion
Within the APOM-project, it is assumed that there is no ’one best way’ to organize
quality, since different opinions exist about the interpretation of good quality.
Pharmacy organization, for example, provides care as a part within the pharmaceuti-
cal business chain. The pharmacy manager selects objectives related to the care for
the patient. In addition, pharmacy organization, as well as any other organization,
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needs turnover in order to sustain its activity. Pharmacy manager selects objectives
related to the economic sustainability of the pharmacy organization. The selection
of the set of objectives will lead to a certain steering mix; the sum total of steering
measures which structures the organization. In the APOM-project three pharmacy
mixes of steering measures or objectives were defined, and, related to the care
orientation and to the economic orientation: the product mix, the process mix, and
the customer mix. The product mix relates to the pharmaceutical product and relates
to the check of this product. The process mix relates to the financial profit in selling
the pharmaceutical product. The customer mix relates to the customer’s satisfaction
of the patients visiting the pharmacy.
In the next phase of the APOM-project it will be studied if ’thinking and acting’
of pharmacy managers correspond within the three pharmacy mixes. It will be
studied if the pharmacy manager who thinks that he is acting in, for example, the
customer mix, actually stresses the package of subjects related to the customer mix.
The pharmacy manager in the example, should stress customer satisfaction, and not,
for example, only maximum profit. It is expected that some of the studied
pharmacies will be internally inconsistent; for example, the pharmacy manager in
the customer mix will act like he/she is in another mix. Argyris [48] showed that
people do not act in correspondence with their espoused theory. The actual behaviour
is in correspondence with another theory: the theory in use. The theory in use must
be traced back from behaviour. The theory in use does not correspond with the
espoused theory. People are not aware of this behaviour. It is assumed that internal
consistency of pharmacy organization will be related to improved manageability of
pharmacy organization. In other words, it is assumed that improved correspondence
of ’thinking and acting’ will lead to an effective structure of the organization. By
analogy with the contingency approach, consistent steering or organizational ’fit’
is expected to lead to effective structuring. Therefore, it is assumed that correspon-
dence of thinking and acting will lead to improved manageability.
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Finally, within the health-care system, services did become increasingly patient
oriented over the last years. The patient is treated as a customer, rather than as a
patient. Starting from this very position in general, and at pharmacies in particular,
it will be studied what happens if a pharmacy organization will ’travel’ to the
customer mix. If pharmacy organization is internally consistent in its position,
pharmacy organization will be changed in accordance with the customer mix. For
example, the pharmacy manager in the process mix acts like he/she is in the process
mix, will change pharmacy organization to the customer mix. Assuming correspon-
dence of ’thinking and acting’, it will be analyzed what type of organizational
problems the pharmacy manager has to manage, in order to ’travel’ from the process
mix or the product mix to the customer mix.
The APOM-project will provide an insight in the managerial processes of pharmacy
organization, and, in addition, will provide an insight in the structuring and steering
of these managerial processes of pharmacy organization. Ultimately, if the
expectations of the APOM-project will be fulfilled, the pharmacy manager should
be able to improve the manageability of the pharmacy organization.
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